Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: New therapeutics for soft tissue sarcomas. | Front Oncol | 2023 | 37909024 | PubTator, text mining | PubMed |
| Extracellular matrix modulates the spatial hepatic features in hepatocyte-like cells derived from human embryonic stem cells. | Stem Cell Res Ther | 2023 | 37907977 | PubTator, text mining | PubMed |
| [Clinical and ASS1 gene variant analysis of three Chinese pedigrees affected with Citrullinemia type I]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37906139 | PubTator, text mining | PubMed |
| Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy. | RSC Adv | 2023 | 37901257 | PubTator, text mining | PubMed |
| Characteristics of amino acid metabolism in colorectal cancer. | World J Clin Cases | 2023 | 37900242 | PubTator, text mining | PubMed |
| Proposing a novel molecular subtyping scheme for predicting distant recurrence-free survival in breast cancer post-neoadjuvant chemotherapy with close correlation to metabolism and senescence. | Front Endocrinol (Lausanne) | 2023 | 37900131 | PubTator, text mining | PubMed |
| Determination of Carrier Frequency of Actionable Pathogenic Variants in Autosomal Recessive Genetic Diseases in the Turkish Cypriot Population. | Genes (Basel) | 2023 | 37895316 | PubTator, text mining | PubMed |
| Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early Detection of Colorectal Cancer: A Comprehensive Analysis of RNA-Seq Data by Utilizing Machine Learning Algorithms. | Genes (Basel) | 2023 | 37895185 | PubTator, text mining | PubMed |
| Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review. | Int J Mol Sci | 2023 | 37895129 | PubTator, text mining | PubMed |
| Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease. | Biomolecules | 2023 | 37892221 | PubTator, text mining | PubMed |
| Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health. | Cells | 2023 | 37887306 | PubTator, text mining | PubMed |
| Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential. | Sci Rep | 2023 | 37880233 | PubTator, text mining | PubMed |
| Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study. | ESMO Open | 2023 | 37879233 | PubTator, text mining | PubMed |
| To What Extent Does Arginine Reduce the Risk of Developing Necrotizing Enterocolitis? | Cureus | 2023 | 37876383 | PubTator, text mining | PubMed |
| Mechanistic Insight into Poly-Reactivity of Immune Antibodies upon Acid Denaturation or Arginine Mutation in Antigen-Binding Regions. | Antibodies (Basel) | 2023 | 37873861 | PubTator, text mining | PubMed |
| Citrullinemia and What Else? | Endocr Metab Immune Disord Drug Targets | 2023 | 37859410 | PubTator, text mining | PubMed |
| IGF-1R targeting in cancer - does sub-cellular localization matter? | J Exp Clin Cancer Res | 2023 | 37858153 | PubTator, text mining | PubMed |
| Statement of Retraction: N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner. | Bioengineered | 2023 | 37853771 | PubTator, text mining | PubMed |
| Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia. | Cancer Drug Resist | 2023 | 37842232 | PubTator, text mining | PubMed |
| Arginine Expedites Erastin-Induced Ferroptosis through Fumarate. | Int J Mol Sci | 2023 | 37834044 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=14